Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide

J Clin Oncol. 2012 Jul 20;30(21):e180-3. doi: 10.1200/JCO.2011.40.9565. Epub 2012 Jun 11.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / pathology*
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Contrast Media
  • Dacarbazine / administration & dosage
  • Dacarbazine / analogs & derivatives
  • Disease Progression
  • Fatal Outcome
  • Female
  • Gadolinium
  • Glioblastoma / drug therapy*
  • Glioblastoma / pathology*
  • Glioblastoma / radiotherapy
  • Glioblastoma / surgery
  • Humans
  • Lomustine / administration & dosage
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Radiotherapy, Adjuvant
  • Temozolomide
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Alkylating
  • Contrast Media
  • Lomustine
  • Dacarbazine
  • Gadolinium
  • Temozolomide